MYD88 and renal cell carcinoma: Meta-analysis of tumor gene-expression data from RCC patients highlights that the higher expression of IL-1B correlates with pro-tumor genes induced by TAMs and advanced tumor stages, indicating that IL-1/IL-1R signaling is crucial in shaping the TME and the RCC tumor development through MyD88-dependent NF-κB pathway activation [169].